HK1199060A1 - Recombinant escherichia coli strains - Google Patents

Recombinant escherichia coli strains Download PDF

Info

Publication number
HK1199060A1
HK1199060A1 HK14112547.7A HK14112547A HK1199060A1 HK 1199060 A1 HK1199060 A1 HK 1199060A1 HK 14112547 A HK14112547 A HK 14112547A HK 1199060 A1 HK1199060 A1 HK 1199060A1
Authority
HK
Hong Kong
Prior art keywords
coli
protein
defensin
cell
recombinant
Prior art date
Application number
HK14112547.7A
Other languages
English (en)
Chinese (zh)
Inventor
托比亞斯．奧爾施拉格爾
托比亚斯．奥尔施拉格尔
．徐
E．J．徐
簡．韋坎普
简．韦坎普
愛德華．
爱德华．F．施坦格
．施坦格
乌尔里希．索南伯恩
烏爾里希．索南伯恩
于尔根．马林卡
于爾根．馬林卡
汉斯．普罗珀特
漢斯．普羅珀特
Original Assignee
Pharma-Zentrale Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma-Zentrale Gmbh filed Critical Pharma-Zentrale Gmbh
Publication of HK1199060A1 publication Critical patent/HK1199060A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK14112547.7A 2012-02-17 2013-02-14 Recombinant escherichia coli strains HK1199060A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12001091.3A EP2628793A1 (en) 2012-02-17 2012-02-17 Recombinant escherichia coli strains
EP12001091.3 2012-02-17
PCT/EP2013/000446 WO2013120618A1 (en) 2012-02-17 2013-02-14 Recombinant escherichia coli strains

Publications (1)

Publication Number Publication Date
HK1199060A1 true HK1199060A1 (en) 2015-06-19

Family

ID=47843228

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112547.7A HK1199060A1 (en) 2012-02-17 2013-02-14 Recombinant escherichia coli strains

Country Status (9)

Country Link
US (1) US20160015781A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP2628793A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN104126003A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2013220738A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2864870A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EA (1) EA201491513A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK1199060A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN2014DN06920A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2013120618A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110914386A (zh) 2017-06-12 2020-03-24 杜克大学 用于生产生物分子的组合物、系统和方法
CN109504643B (zh) * 2018-11-27 2022-06-10 扬州大学 整合四拷贝功能性f18菌毛操纵子基因的益生菌克隆株、构建方法及应用
US10485632B1 (en) 2018-11-27 2019-11-26 King Saud University Intraoral attachment clip for attachment of objects to edentulous ridges
WO2020165874A1 (en) * 2019-02-15 2020-08-20 Oncosimis Biotech Private Limited A bacterial expression vector for enhanced protein secretion
US12011466B2 (en) * 2019-07-08 2024-06-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Modified Escherichia coli strain Nissle and treatment of gastrointestinal disorder
WO2022067219A1 (en) * 2020-09-28 2022-03-31 The Regents Of The University Of Michigan Methods and compositions for intestinal inflammation
CN115521884B (zh) * 2022-07-20 2023-12-29 四川宏展致远环保科技有限公司 一种类芽孢杆菌hnp12及其应用
CN116496916A (zh) * 2022-12-27 2023-07-28 安徽斯拜科生物科技有限公司 一种高产hbd-2的毕赤酵母工程菌株及其制备方法和应用
CN118931930B (zh) * 2023-05-09 2025-08-01 汤臣倍健股份有限公司 基于T7表达系统的Nissle 1917工程菌、其制备方法及应用
CN116769814B (zh) * 2023-06-16 2024-02-02 苏州泓迅生物科技股份有限公司 一种大肠杆菌益生菌t7表达系统及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010049807A2 (en) * 2008-10-30 2010-05-06 Gene Bridges Gmbh Method for recombinant expression of polypeptides

Also Published As

Publication number Publication date
AU2013220738A1 (en) 2014-09-04
CA2864870A1 (en) 2013-08-22
CN104126003A (zh) 2014-10-29
WO2013120618A1 (en) 2013-08-22
IN2014DN06920A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2015-04-10
EP2628793A1 (en) 2013-08-21
AU2013220738A9 (en) 2014-10-16
US20160015781A1 (en) 2016-01-21
EA201491513A1 (ru) 2015-01-30

Similar Documents

Publication Publication Date Title
Seo et al. Construction of recombinant E. coli Nissle 1917 (EcN) strains for the expression and secretion of defensins
HK1199060A1 (en) Recombinant escherichia coli strains
EP3350322B1 (en) A novel endolysin polypeptide
US11850268B2 (en) Engineered bacteria secreting therapeutic proteins and methods of use thereof
US9040302B2 (en) Genetically modified Streptococcus thermophilus bacterium
JP6351119B2 (ja) サルモネラの生物的防除のための及び食品の製造若しくは加工におけるバクテリオファージ
JP6714902B2 (ja) ペプチドおよびタンパク質の発現のための方法
Sichwart et al. Maximized autotransporter-mediated expression (MATE) for surface display and secretion of recombinant proteins in Escherichia coli
WO2015078840A1 (en) Full and partial protein secretion and cell surface display using type iii secretion system
Class et al. Patent application title: Recombinant Escherichia Coli Strains
CN116949027A (zh) 一种尿路致病性大肠埃希菌重组蛋白组合物ls、其构建、表达、纯化方法及其应用
WO2021212122A2 (en) Engineered probiotics for treatment and immunity against viruses
Bryant Substrate targeting and recognition in the flagellar type III secretion pathway
EP4377332A2 (en) Il-10 inducing polypeptides and uses thereof
Jarrell Effect of changes at the conserved+ 3 position of mature archaellins on in vitro cleavage by the pre-archaellin peptidase FlaK of Methanococcus maripaludis
US20220280580A1 (en) Lactococcal expression of il-35 for treatment of disease
Diao et al. Novel inhibitors of E. coli lipoprotein diacylglyceryl transferase are insensitive to resistance caused by lpp deletion
Portt Substrate specificities of outer membrane proteases of the omptin family in «Escherichia coli, Salmonella enterica, and Citrobacter rodentium»
HK1258877B (en) A novel endolysin polypeptide